Research Articles
Silencing Cancer's Messenger: How AC1MMYR2 Tames Rogue miRNA to Halt Tumors
Discover how AC1MMYR2, a revolutionary small molecule inhibitor, targets miR-21 biogenesis to reverse epithelial-mesenchymal transition and suppress tumor growth in multiple cancer types.
Targeting the Untouchable: How Protein Degraders Are Taking Aim at Cancer's "Undruggable" MYC
Explore how protein degrader technology is revolutionizing cancer treatment by targeting the once 'undruggable' MYC oncoprotein, a master regulator in 70% of human cancers.
Nanoplatforms for Targeted Delivery of Irinotecan: A New Era in Cancer Therapy
Explore how nanotechnology is revolutionizing cancer treatment through targeted delivery of irinotecan, reducing side effects and improving efficacy.
Monoclonal Antibodies: The Guided Missiles Revolutionizing Cancer Therapy
Explore how monoclonal antibodies have evolved from scientific concept to clinical reality, revolutionizing our approach to cancer treatment through targeted therapy.